BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 952 filers reported holding BAXTER INTL INC in Q1 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,027,000 | +273.5% | 11,969 | +249.7% | 0.01% | +1100.0% |
| Q3 2021 | $275,000 | -77.2% | 3,423 | -77.2% | 0.00% | -94.7% |
| Q3 2020 | $1,208,000 | -40.9% | 15,023 | -36.8% | 0.02% | -53.7% |
| Q2 2020 | $2,045,000 | -14.6% | 23,757 | -19.5% | 0.04% | -36.9% |
| Q1 2020 | $2,395,000 | -41.7% | 29,504 | -39.9% | 0.06% | -14.5% |
| Q4 2019 | $4,106,000 | +34.1% | 49,107 | +40.3% | 0.08% | +38.2% |
| Q3 2019 | $3,062,000 | -54.5% | 35,006 | -57.4% | 0.06% | -55.6% |
| Q2 2019 | $6,726,000 | +506.5% | 82,125 | +501.9% | 0.12% | +439.1% |
| Q1 2019 | $1,109,000 | -76.2% | 13,645 | -80.7% | 0.02% | -80.2% |
| Q4 2018 | $4,665,000 | -65.3% | 70,876 | -59.3% | 0.12% | -38.9% |
| Q3 2018 | $13,434,000 | +21.5% | 174,268 | +16.3% | 0.19% | +24.2% |
| Q2 2018 | $11,061,000 | -18.3% | 149,793 | -28.1% | 0.15% | -24.6% |
| Q1 2018 | $13,543,000 | -13.5% | 208,228 | -14.0% | 0.20% | +5.2% |
| Q4 2017 | $15,654,000 | +10.7% | 242,171 | +7.5% | 0.19% | +3.2% |
| Q3 2017 | $14,139,000 | +13.1% | 225,330 | +9.1% | 0.19% | +25.5% |
| Q2 2017 | $12,499,000 | +42.7% | 206,456 | +22.3% | 0.15% | +47.5% |
| Q1 2017 | $8,756,000 | +22.0% | 168,845 | +4.3% | 0.10% | +34.7% |
| Q4 2016 | $7,175,000 | -16.1% | 161,813 | -9.9% | 0.08% | -10.7% |
| Q3 2016 | $8,553,000 | +3.5% | 179,677 | -1.6% | 0.08% | -8.7% |
| Q2 2016 | $8,261,000 | +21.9% | 182,685 | +10.7% | 0.09% | +31.4% |
| Q1 2016 | $6,776,000 | +31.2% | 164,953 | +21.8% | 0.07% | +40.0% |
| Q4 2015 | $5,165,000 | +27.4% | 135,386 | +9.7% | 0.05% | +35.1% |
| Q3 2015 | $4,055,000 | -63.8% | 123,432 | -23.0% | 0.04% | -51.9% |
| Q2 2015 | $11,217,000 | +5.1% | 160,403 | +2.9% | 0.08% | -1.3% |
| Q1 2015 | $10,673,000 | +68.8% | 155,814 | +80.6% | 0.08% | +62.5% |
| Q4 2014 | $6,324,000 | -9.9% | 86,285 | -11.8% | 0.05% | -14.3% |
| Q3 2014 | $7,017,000 | +8.0% | 97,774 | +8.8% | 0.06% | +7.7% |
| Q2 2014 | $6,500,000 | -38.8% | 89,904 | -37.7% | 0.05% | -44.1% |
| Q1 2014 | $10,623,000 | -38.7% | 144,374 | -42.1% | 0.09% | -34.5% |
| Q4 2013 | $17,334,000 | -2.4% | 249,230 | -7.8% | 0.14% | +8.4% |
| Q3 2013 | $17,760,000 | +5.6% | 270,363 | +11.3% | 0.13% | +5.6% |
| Q2 2013 | $16,822,000 | – | 242,842 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |